Papillary carcinoma of the thyroid (PTC) is the most common differentiated thyroid tumor. Its occurrence is closely associated with mutations in oncogenes such as
BRAF
RAS
RET
and
TERT
. Different oncogene mutations may result in biological behaviors and tumor growth patterns of PTC that exhibit various ultrasound features. With the progression of molecular biology technology in recent years
number of researchers have attempted to investigate the correlation between PTC molecular markers and ultrasound features. A thorough understanding of the relationship between PTC molecular markers and ultrasound features can helpassess the overall risk and potential molecular characteristics. This will contribut
e to an individualized assessment of PTC and is essential to the logical formulation of the follow-up diagnosis and treatment plan.
The correlation between clinical and ultrasound features of papillary carcinoma of the thyroid and central lymph node metastasis and BRAF V600E gene mutation
Prediction of central lymph node metastasis in papillary carcinoma of the thyroid by nomogram based on ultrasonographic features
The value of diagnostic 131 I scan in PTC patients with unexplained hyperthyroglobulinemia